Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $132.67 | 3 | 62.0% |
| Food and Beverage | $81.20 | 2 | 38.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $110.25 | 1 | $0 (2017) |
| Genentech USA, Inc. | $61.96 | 1 | $0 (2017) |
| Kyowa Kirin, Inc. | $19.24 | 1 | $0 (2021) |
| CSL Behring | $11.26 | 1 | $0 (2020) |
| Akcea Therapeutics, Inc. | $11.16 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $30.40 | 2 | Kyowa Kirin, Inc. ($19.24) |
| 2020 | $11.26 | 1 | CSL Behring ($11.26) |
| 2017 | $172.21 | 2 | Teva Pharmaceuticals USA, Inc. ($110.25) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2021 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 03/18/2021 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Education | In-kind items and services | $11.16 | General |
| Category: NEUROLOGY | ||||||
| 01/14/2020 | CSL Behring | Hizentra (Biological) | Education | In-kind items and services | $11.26 | General |
| Category: Immunology | ||||||
| 05/11/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $61.96 | General |
| Category: None | ||||||
| 03/08/2017 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $110.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,605 | 1,972 | $741,494 | $209,748 |
| 2022 | 12 | 1,708 | 2,098 | $779,030 | $234,358 |
| 2021 | 12 | 1,693 | 2,090 | $761,953 | $239,683 |
| 2020 | 14 | 1,552 | 1,846 | $620,955 | $180,471 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 721 | 946 | $306,059 | $89,584 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 223 | 269 | $116,383 | $37,371 | 32.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 185 | 277 | $82,846 | $22,687 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 100 | 100 | $61,494 | $16,756 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $47,140 | $11,594 | 24.6% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 35 | 35 | $28,735 | $7,183 | 25.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 38 | 38 | $27,930 | $6,729 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 93 | $20,454 | $6,202 | 30.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 53 | 53 | $24,168 | $5,610 | 23.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 24 | 24 | $14,616 | $3,286 | 22.5% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 29 | 29 | $10,875 | $2,397 | 22.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 13 | $794.00 | $350.48 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 718 | 971 | $305,236 | $94,604 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 230 | 271 | $113,429 | $40,084 | 35.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 218 | 306 | $88,434 | $26,687 | 30.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 101 | 101 | $60,253 | $17,546 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 135 | 135 | $64,936 | $16,908 | 26.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 42 | 42 | $30,870 | $7,905 | 25.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 66 | 67 | $29,736 | $7,891 | 26.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 38 | 38 | $31,198 | $7,718 | 24.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 49 | 49 | $29,841 | $7,262 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 77 | $16,498 | $5,303 | 32.1% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 22 | 22 | $7,886 | $1,918 | 24.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 17 | 19 | $713.00 | $533.17 | 74.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 681 | 948 | $291,984 | $95,142 | 32.6% |
About Dr. Seth Haplea, M.D
Dr. Seth Haplea, M.D is a Neurology healthcare provider based in Kennett Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467408906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Haplea, M.D has received a total of $213.87 in payments from pharmaceutical and medical device companies, with $30.40 received in 2021. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Education" ($132.67).
As a Medicare-enrolled provider, Haplea has provided services to 6,558 Medicare beneficiaries, totaling 8,006 services with total Medicare billing of $864,261. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Kennett Square, PA
- Active Since 05/26/2006
- Last Updated 07/28/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467408906
Products in Payments
- Non-Covered Product (Drug) $61.96
- NOURIANZ (Drug) $19.24
- Hizentra (Biological) $11.26
- TEGSEDI (Drug) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.